Faculty Opinions recommendation of Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Anticoagulant Therapy ◽

Oral Anticoagulant ◽

Controlled Trial ◽

Coronary Intervention ◽

Open Label ◽

Percutaneous Coronary ◽

Faculty Opinions recommendation of Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717985563.793512937 ◽

2016 ◽

Author(s):

Nanette Wenger

Keyword(s):

Anticoagulant Therapy ◽

Oral Anticoagulant ◽

Controlled Trial ◽

Coronary Intervention ◽

Open Label ◽

Percutaneous Coronary ◽

Faculty Opinions recommendation of Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717985563.793476543 ◽

2013 ◽

Author(s):

Venu Menon ◽

Bhuvnesh Aggarwal

Keyword(s):

Anticoagulant Therapy ◽

Oral Anticoagulant ◽

Controlled Trial ◽

Coronary Intervention ◽

Open Label ◽

Percutaneous Coronary ◽

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

The Lancet ◽

10.1016/s0140-6736(12)62177-1 ◽

2013 ◽

Vol 381 (9872) ◽

pp. 1107-1115 ◽

Cited By ~ 1028

Author(s):

Willem JM Dewilde ◽

Tom Oirbans ◽

Freek WA Verheugt ◽

Johannes C Kelder ◽

Bart JGL De Smet ◽

...

Keyword(s):

Anticoagulant Therapy ◽

Oral Anticoagulant ◽

Controlled Trial ◽

Coronary Intervention ◽

Open Label ◽

Percutaneous Coronary ◽

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(14)60924-7 ◽

2014 ◽

Vol 384 (9957) ◽

pp. 1849-1858 ◽

Cited By ~ 351

Author(s):

Adeel Shahzad ◽

Ian Kemp ◽

Christine Mars ◽

Keith Wilson ◽

Claire Roome ◽

...

Keyword(s):

Unfractionated Heparin ◽

Primary Percutaneous Coronary Intervention ◽

Controlled Trial ◽

Coronary Intervention ◽

Single Centre ◽

Open Label ◽

Percutaneous Coronary ◽

Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention

JACC Cardiovascular Interventions ◽

10.1016/j.jcin.2021.01.022 ◽

2021 ◽

Vol 14 (7) ◽

pp. 754-763 ◽

Cited By ~ 1

Author(s):

Dimitrios Venetsanos ◽

Mikolaj Skibniewski ◽

Magnus Janzon ◽

Sofia S. Lawesson ◽

Emmanouil Charitakis ◽

...

Keyword(s):

Anticoagulant Therapy ◽

Oral Anticoagulant ◽

Coronary Intervention ◽

Oral Anticoagulant Therapy Post-Percutaneous Coronary Intervention

Oral Anticoagulation Therapy ◽

10.1007/978-3-319-54643-8_25 ◽

2017 ◽

pp. 173-179

Author(s):

Craig J. Beavers

Keyword(s):

Anticoagulant Therapy ◽

Oral Anticoagulant ◽

Coronary Intervention ◽

The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial

Trials ◽

10.1186/1745-6215-15-371 ◽

2014 ◽

Vol 15 (1) ◽

Cited By ~ 11

Author(s):

Sheraz A Nazir ◽

Jamal N Khan ◽

Islam Z Mahmoud ◽

John P Greenwood ◽

Daniel J Blackman ◽

...

Keyword(s):

Infarct Size ◽

Primary Percutaneous Coronary Intervention ◽

Intervention Study ◽

Microvascular Obstruction ◽

Controlled Trial ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

USE OF ORAL ANTICOAGULANT THERAPY AMONG REAL-WORLD PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(16)30179-6 ◽

2016 ◽

Vol 67 (13) ◽

pp. 178

Author(s):

Eric Alexander Secemsky ◽

Neel Butala ◽

Uri Kartoun ◽

Sadiqa Mahmood ◽

Stanley Shaw ◽

...

Keyword(s):

Anticoagulant Therapy ◽

Real World ◽

Oral Anticoagulant ◽

Coronary Intervention ◽

Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial

International Journal of Cardiology ◽

10.1016/j.ijcard.2015.07.108 ◽

2015 ◽

Vol 201 ◽

pp. 237-242 ◽

Cited By ~ 21

Author(s):

Eric Chong ◽

Kian-Keong Poh ◽

Qingshu Lu ◽

James Jun-Jie Zhang ◽

Ning Tan ◽

...

Keyword(s):

Controlled Trial ◽

Coronary Intervention ◽

High Dose ◽

Contrast Induced Nephropathy ◽

Percutaneous Coronary ◽

Dose Oral ◽

Randomised Controlled ◽

Intravenous Sodium

Switching Oral Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

JACC Cardiovascular Interventions ◽

10.1016/j.jcin.2019.10.017 ◽

2019 ◽

Vol 12 (23) ◽

pp. 2342-2345

Author(s):

Francesco Franchi ◽

Fabiana Rollini

Keyword(s):

Atrial Fibrillation ◽

Anticoagulant Therapy ◽

Oral Anticoagulant ◽

Coronary Intervention ◽